Nezelot syndrome
Nozelof’s syndrome, also known as thymic dysplasia syndrome, was first reported by French pathologist Nozelof (1964). It is a T lymphocyte immunodeficiency accompanied by thymic dysplasia. Immunoglobulin values may be normal or elevated, and some are accompanied by one or more selective defects of immunoglobulins. Even if the immunoglobulin concentration is normal, specific antibody reactions are often affected.
-
Site of disease:
Mediastinal immune system -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Recurrent pneumonia Candida albicans infection Indigestion Fever in children
Related Drugs
Mannan peptide tablets
Indication: Used as an adjuvant treatment for immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumor treatment, and to reduce the side effects of radiotherapy and chemotherapy on the hematopoietic system and gastrointestinal reactions.
Manufacturer:
Zhejiang Ruibang Pharmaceutical Co., Ltd.
Thymosin enteric-coated tablets
Indication: Used for: ① For chronic hepatitis B patients over 18 years old. After 18 years old, the thymus begins to shrink and the cellular immune function is reduced; ② Various primary or secondary T cell deficiency diseases; ③ Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); ④ Various diseases with low cellular immune function; ⑤ Adjuvant treatment of tumors.
Manufacturer:
Harbin Xinnongda Food Co., Ltd.